key: cord-0931349-3yspi0ys authors: Westhaus, Sandra; Widera, Marek; Rabenau, Holger F.; Hoehl, Sebastian; Bojkova, Denisa; Cinatl, Jindrich; Ciesek, Sandra title: Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings date: 2020-09-13 journal: bioRxiv DOI: 10.1101/2020.09.11.292581 sha: c7309174b04c4d2f71cd0437c4e86a9f5a4e4f11 doc_id: 931349 cord_uid: 3yspi0ys The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Laboratory work with SARS-CoV-2 in a laboratory setting was rated to biosafety level 3 (BSL-3) biocontainment level. However, certain research applications in particular in molecular biology require incomplete denaturation of the proteins, which might cause safety issues handling contaminated samples. In particular, it is critical to provide proof of inactivation before samples can be removed from the BSL-3. In this study, we evaluated common lysis buffers that are used in molecular biological laboratories for their ability to inactivate SARS-CoV-2. We have found that guanidine thiocyanate, SDS, and Triton-X containing lysis buffers were effective in inactivation of SARS-CoV-2, however, the M-PER lysis buffer containing a proprietary detergent failed to inactivate SARS-CoV-2. Furthermore, we compared chemical and non-chemical inactivation methods including ethanol, acetone-methanol mixture, PFA, UV-C light, and heat inactivation. In addition, the stability of the virus in cell culture media at 4°C and on surfaces used in laboratory environment was analyzed. In conclusion, careful evaluation of the used inactivation methods are required and additional inactivation steps are necessary before removal of lysed viral samples from BSL-3. In addition, it might be assumed SARS-CoV-2 can remain infectious for much longer period of time when 56 stored in liquid milieu at appropriate temperatures. This is the case in laboratory environments in which 57 the condition of the sample has to be partially preserved for the subsequent molecular biological assays. Infectious titer of SARS-CoV-2 supernatant were determined by an end-point limiting dilution assay. Briefly, Caco-2 were seeded onto a 96-well plate and infected with untreated or treated SARS-CoV-2 79 containing supernatant in an initial 1:10 dilution (quadruplicates). Titration was performed on 96-well 80 plate with ten serial 1:10 dilutions. Viral titer was determined 48h post infection as 50% tissue culture 81 infectious dose (TCID50) as described by Spearman and Kaerber (Kärber, 1931) . To analyze inhibition 82 capacity of different inactivation methods viral titers were normalized to the untreated control and 83 reduction factor was calculated as described elsewhere (Rabenau et al., 2005b Statistical significance compared to untreated control was determined using unpaired student's t-test. Asterisks indicated p-values as * (p < 0.05), ** (p ≤ 0.01) and *** (p ≤ 0.005). and without protection glass).TCID50 using CaCo2-cells was performed to determine viral infectivity. Since coronaviruses were shown to remain infectious on commonly used touch surface materials These data indicate that it is particularly important to inactivate contaminated material and instruments 168 before continue working under less stringent safety requirements. Germany) we were able to demonstrate complete inactivation (Table 2, Supplementary Figure 1 ). Importantly, Mammalian Protein Extraction Reagent (M-PER) (ThermoFisher) was not able to inactivate 216 SARS-CoV-2 (Figure 2, Table 2 ). As determined using crystal violet staining, only 22% of the cells were 217 inactivated, which was comparable to the untreated control (18%). This data was confirmed by RT- These findings highlight the fact that careful evaluation of the used inactivation methods are required 221 and that additional inactivation steps might be necessary to prepare the samples for safe processing. (Table 4) . However, ethanol/PBS (50%, 1:1) did not inactivate SARS- CoV-2, which was in line with previously published data (Kratzel et al., 2020b) . representative of a seasonally recurring respiratory pathogen. To mimic daily laboratory 255 decontamination routines, we exposed SARS-CoV-2 contaminated samples in a biological safety 256 cabinet to UV light and irradiated for 15-60 min. We found that 15 min were already highly efficient and 257 30 min as well as 60 min completely inactivated SARS-CoV-2 infectivity. In addition, we used two 258 different UV light sources with a discharge lamp (low pressure radiation chamber) or a highly potent 259 LED UV light to inactivate contaminated surfaces. We compared different exposure times ranging from 260 2 -210 seconds for UV-C discharge lamp and 0.5 -3.5 seconds for UV-C LED with fixed distances of 261 20 to 40 mm to the light source, respectively. Using UV light from the discharge lamp, 2 seconds 262 exposure time resulted in a minimal reduction factor of 3.5 log while after 4 seconds no infectious SARS- CoV-2 was detected in the viral outgrowth assay (Figure 3, Table 5 ). One second UV-C LED was 264 sufficient to reduce viral infectivity by 3.9 log. 3.5 seconds completely reduced viral titers >4 log. In agreement with previously studies we found that most inactivation methods were effective. In Of note, inactivation efficiency largely depends on the initial virus load and the reaction volume. Especially in the case of heat inactivation, the heating time of the respective medium must be 310 considered. In addition, the higher the virus titer, the longer the inactivation time is necessary for In comparison to the Triton-X-containing lysis buffers used for enzyme based assays (e.g. luciferase based measurements), we found that the commercially available M-PER buffer (Thermo Scientific) was Identification of a novel coronavirus in patients with severe acute 356 respiratory syndrome Stability of SARS coronavirus in human 359 specimens and environment and its sensitivity to heating and UV irradiation Human coronaviruses: insights into 362 environmental resistance and its influence on the development of new antiseptic 363 strategies Evidence of SARS-CoV-2 Infection in Returning Travelers from 368 The New England journal of medicine Corrigendum to "Persistence of 370 coronaviruses on inanimate surfaces and their inactivation with biocidal agents Persistence of coronaviruses on 373 inanimate surfaces and their inactivation with biocidal agents Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche Archiv für experimentelle pathologie und pharmakologie 162 How long do nosocomial pathogens persist on 379 inanimate surfaces? A systematic review Temperature-dependent surface stability of 382 SARS-CoV-2 Inactivation of Severe Acute Respiratory Syndrome 386 Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols 389 Stability and inactivation of SARS coronavirus Efficacy of various disinfectants 392 against SARS coronavirus Optimized qRT-PCR Approach for the 395 Detection of Intra-and Extra-Cellular SARS-CoV-2 RNAs. International journal of 396 molecular sciences 21 Stability of Middle East respiratory 398 syndrome coronavirus (MERS-CoV) under different environmental conditions Human Coronavirus 229E Remains 401 Infectious on Common Touch Surface Materials WHO. 2020. WHO SARS-CoV-2 situation report 182 A Novel Coronavirus from Patients with 407 Pneumonia in China